News

Thomas E. Menighan Honored with 2026 Remington Medal Award

Thomas E. Menighan Honored with 2026 Remington Medal Award

Thomas E. Menighan Receives Prestigious Remington Honor Medal

The American Pharmacists Association (APhA) joyfully announces that Thomas E. Menighan, BSPharm, MBA, ScD, has been honored with the 2026 Remington Honor Medal. This distinguished award signifies the highest achievement in the pharmacy profession, celebrating a lifetime of significant contributions to the field.

Understanding the Remington Honor Medal

Named after Joseph P. Remington, an esteemed community pharmacist and educator, this medal embodies excellence in the pharmacy sector. It acknowledges extraordinary contributions whether made over the past year or across a lifelong career dedicated to advancing pharmacy practice.

The Impact of Thomas E. Menighan

Michael D. Hogue, PharmD, FAPhA, FNAP, and executive vice president and CEO of APhA remarked, "The Remington Honor Medal represents the pinnacle of achievement in our profession. Tom Menighan is a humble leader who uplifts others. He truly deserves this recognition for his significant impact across various facets of pharmacy."

A formal presentation of this prestigious award will occur during APhA's upcoming 2026 Annual Meeting & Exposition, where Menighan will also deliver the annual Remington Lecture.

A Distinguished Career in Pharmacy

Menighan's career is a beacon of excellence, having shaped pharmacy practice, health policies, and professional development throughout his years of service. He has been an innovator, influencing nearly all segments of the pharmacy landscape.

"This award is recognition to be shared with the many partners, mentors, and colleagues who have inspired advancements together, promoting access to quality patient care services," Menighan stated, acknowledging the collaborative spirit of the pharmacy community.

Menighan's Journey and Achievements

From 2009 to 2020, Menighan served as APhA's CEO and executive vice president, succeeding a successful role as senior director of external affairs. His leadership saw the initiation of groundbreaking initiatives, such as securing provider status for pharmacists at a national level and expanding resources like the Pharmacy Library and Pharmacy Profiles.

Menighan's influence does not stop at APhA. He currently holds the position of Assistant Dean for Community Engagement at the West Virginia University School of Pharmacy and is a co-founder of PursueCare and PursueCareRx, focusing on pharmacy and behavioral telehealth services. Furthermore, he plays a vital role in the West Virginia Drug Intervention Institute, an organization dedicated to educating youth on safe medication practices.

Leadership Beyond Pharmacy

His extensive contributions span various organizations, including board roles at the United States Pharmacopeia (USP) and the International Pharmaceutical Federation (FIP). Menighan has also ventured into entrepreneurship, leading initiatives in community pharmacy, telehealth, and pharmaceutical auditing.

Hailing from Sistersville, WV, Menighan is a proud alumnus of West Virginia University, where he earned his degree in pharmacy. His dedication to education and mentorship is evident in his establishment of the APhA Menighan Leadership Scholarship and contributions to the WVU Menighan Leadership Fund for Pharmacy.

Menighan’s achievements have earned him numerous accolades, reflecting his dedication to the profession and his unwavering commitment to nurturing future pharmacy leaders.

About the American Pharmacists Association

Established in 1852, APhA is the sole organization committed to advancing the entire pharmacy profession. Located in Washington, DC, APhA advocates for pharmacists and technicians, enhancing medication use and patient health outcomes. Through its esteemed educational programs, resources, and advocacy initiatives, APhA leads efforts to develop national policies and practices that benefit the profession and improve patient care.

Frequently Asked Questions

What is the Remington Honor Medal?

The Remington Honor Medal is the highest recognition in the pharmacy profession, awarded for significant contributions over a lifetime.

Who is Thomas E. Menighan?

Thomas E. Menighan is a pharmacy leader and the 2026 recipient of the Remington Honor Medal, recognized for his impactful contributions to the field.

When will the award be presented?

The formal award presentation will be held at APhA's 2026 Annual Meeting & Exposition.

What has been Menighan's role at APhA?

Menighan served as CEO and executive vice president of APhA, leading numerous initiatives to enhance the pharmacy profession.

How has Menighan contributed to pharmacy education?

He co-founded leadership scholarships and funds aimed at supporting upcoming pharmacy leaders and educational initiatives.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Volt Lithium's Role in Upcoming Investor Gatherings

Updated Category News Views 71

Exciting Conference Participation by Volt Lithium Volt Lithium Corp. (TSXV: VLT, VLTLF), also known as "Volt," is gearing up for some exciting industry events. The company is focused on positioning itself as a leader in the lithium production arena, particularly through the extraction of lithium from oilfield brine. With the growing demand for lithium, Volt aims to...

Continue Reading
Tesla's Breakout Signals Promising Path Toward Growth

Updated Category News Views 342

Understanding Tesla's Recent Stock Movement After an extended period of price consolidation within a narrowing pennant formation, Tesla (NASDAQ: TSLA) Inc. experienced a notable breakout recently. The stock observed an impressive 12% surge over three sessions, decisively breaking above the resistance level that had constrained its momentum since late spring. This shift is...

Continue Reading
Exploring MCF Energy's Progress and Future in Gas Development

Updated Category News Views 132

MCF Energy's Advancements in German Gas Exploration MCF Energy Ltd. (TSXV: MCF, OTCQX: MCFNF) has made significant strides recently regarding its Kinsau-1A well. This operational update sheds light on their drilling activities, highlighting how close the new well is to the original Mobil gas discovery. The Kinsau-1A well has reached a remarkable depth of 3310 meters,...

Continue Reading
Vi's AI Reports Set a Transformational Benchmark for Health

Updated Category News Views 158

Vi Unveils Groundbreaking AI Reports for 2026 In a remarkable development for the healthcare industry, Vi, the innovative AI entity powering an extensive network of health enterprises, has released its vital State of AI reports for 2026. This year’s reports focus on three significant sectors: Healthcare, Biopharma, and Wellness. Each report showcases an in-depth...

Continue Reading
BioAge Labs Under Investigation: What Shareholders Should Know

Updated Category News Views 210

Understanding the Investigation into BioAge Labs Recently, an investigation has been initiated to assess the situation at BioAge Labs, Inc. (NASDAQ: BIOA), focusing on possible violations of federal securities laws. This legal inquiry arises from significant developments in the company that have raised concerns among investors. The Role of Bleichmar Fonti & Auld LLP This...

Continue Reading